ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives […]
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives […]
Enters 2020 with a Strong Balance Sheet and an Advancing Clinical PipelineConference Call Begins at 11:00 a.m. Eastern Time on […]
GAITHERSBURG, Md., March 25, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and […]
PALO ALTO, Calif., March 25, 2020 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) today issued the following letter to shareholders:Dear […]
CHICAGO, March 25, 2020 (GLOBE NEWSWIRE) — SP Plus Corporation (SP+), (Nasdaq: SP), a leading provider of technology-driven mobility solutions […]
IntentKey generated approximately $8.5 million in revenue for the full year 2019IntentKey revenue is expected to increase 48% in the […]
Amendment provides covenant relief McLaughlin named CFO following his service as interim CFO since January 2020SANTA CLARA, Calif., March 25, 2020 […]
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a […]
VANCOUVER, British Columbia, March 25, 2020 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer […]
SAN FRANCISCO, March 25, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development […]